双林生物:2020年第四次临时股东大会决议公告

   证券代码:000403            证券简称:双林生物            公告编号:2020-057
                         南方双林生物制药股份有限公司
                       2020年第四次临时股东大会决议公告
        本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、误导性陈
    述或者重大遗漏。


       特别提示:
       本次股东大会的议案全部获得通过,未出现否决议案的情形。
       本次股东大会不涉及变更前次股东大会已通过的决议。

       一、会议召开和出席情况
       (一)会议召开情况:
       1、召开时间:
       (1)现场会议时间:2020 年 07 月 20 日(星期一)下午 2:30
       (2)网络投票时间:其中,通过深圳证券交易所交易系统网络投票的时间为:
   2020 年 7 月 20 日上午 9:15—9:25,9:30—11:30,下午 1:00—3:00;通过深圳
   证券交易所互联网投票系统网络投票时间为:2020 年 7 月 20 日上午 9:15 至下午
   15:00 期间的任意时间。

       2、现场会议地点:广东省湛江市开发区乐山路 27 号财富汇金融中心 1604 号会
   议室。
       3、会议召开方式:现场投票与网络投票相结合方式
       4、会议召集人:公司董事会
       5、会议主持人:董事长黄灵谋先生
       6、本次会议的召开符合《公司法》、《证券法》、《上市公司股东大会规则》以及
   《公司章程》的有关规定。
       (二)出席会议股东情况

现场会议出席情况                     网络投票情况                        总体出席情况




                                                                                       1
                    占该类别有表                               占该类别有表                                  占该类别有
人                                      人                                       人
     代表股份数     决权总股份数               代表股份数      决权总股份数                代表股份数        表决权总股
数                                      数                                       数
                        比例                                       比例                                        份数比例

1      259,200         0.0945%          161   192,543,068        70.1758%       162        192,802,268           70.2702%

                 (三)公司部分董事、监事、高级管理人员出席或列席了本次股东大会,北京
          市嘉源律师事务所见证律师出席并见证了本次股东大会。

                 二、提案审议表决情况
                 本次股东大会审议十七项议案,议案经表决获得通过,具体表决情况见下表:

                                                        同意                        反对                    弃权
       议案名称                  类别
                                                 股数           比例         股数          比例      股数           比例

议案 1:关于公司发行股份
                         总体                 56,034,071       99.7566%     136,702    0.2434%               0    0.0000%
及支付现金购买资产并募
集配套资金暨关联交易符
合相关法律、法规规定的
                         中小投资者           56,034,071       99.7566%     136,702    0.2434%               0    0.0000%
议案


议案 2:关于公司发行股份
及支付现金购买资产暨关
联交易方案的议案

                           总体               106,998,246      99.8724%     136,702    0.1276%               0    0.0000%
议案 2.01:交易对方
                           中小投资者         56,034,071       99.7566%     136,702    0.2434%               0    0.0000%

                           总体               106,998,246      99.8724%     136,702    0.1276%               0    0.0000%
议案 2.02:标的资产
                           中小投资者         56,034,071       99.7566%     136,702    0.2434%               0    0.0000%

议案 2.03:标的资产的定 总体                  106,908,246      99.7884%     226,702    0.2116%               0    0.0000%
价依据及交易价格        中小投资者            55,944,071       99.5964%     226,702    0.4036%               0    0.0000%

议案 2.04:标的资产对价 总体                  106,998,246      99.8724%     136,702    0.1276%               0    0.0000%
支付方式                中小投资者            56,034,071       99.7566%     136,702    0.2434%               0    0.0000%

议案 2.05:本次发行股票 总体                  106,908,246      99.7884%     226,702    0.2116%               0    0.0000%
的种类和面值            中小投资者            55,944,071       99.5964%     226,702    0.4036%               0    0.0000%

议案 2.06:发行方式        总体               106,998,246      99.8724%     136,702    0.1276%               0    0.0000%



                                                                                                         2
                           中小投资者   56,034,071    99.7566%   136,702   0.2434%         0   0.0000%

议案 2.07:发行对象和认 总体            106,998,246   99.8724%   136,702   0.1276%         0   0.0000%
购方式                  中小投资者      56,034,071    99.7566%   136,702   0.2434%         0   0.0000%

                           总体         106,907,946   99.7881%   227,002   0.2119%         0   0.0000%
议案 2.08:发行价格
                           中小投资者   55,943,771    99.5959%   227,002   0.4041%         0   0.0000%

                           总体         106,907,946   99.7881%   227,002   0.2119%         0   0.0000%
议案 2.09:发行数量
                           中小投资者   55,943,771    99.5959%   227,002   0.4041%         0   0.0000%

                           总体         106,998,246   99.8724%   136,702   0.1276%         0   0.0000%
议案 2.10:限售期安排
                           中小投资者   56,034,071    99.7566%   136,702   0.2434%         0   0.0000%

                           总体         106,998,246   99.8724%   136,702   0.1276%         0   0.0000%
议案 2.11:现金对价支付
                           中小投资者   56,034,071    99.7566%   136,702   0.2434%         0   0.0000%

议案 2.12:标的资产过渡 总体            106,998,246   99.8724%   136,702   0.1276%         0   0.0000%
期间损益归属            中小投资者      56,034,071    99.7566%   136,702   0.2434%         0   0.0000%
议案 2.13:关于本次交易 总体            106,998,246   99.8724%   136,702   0.1276%         0   0.0000%
涉及的业绩承诺补偿及超
额业绩奖励事宜          中小投资者      56,034,071    99.7566%   136,702   0.2434%         0   0.0000%

议案 2.14:标的资产权属 总体            106,998,246   99.8724%   136,702   0.1276%         0   0.0000%
转移及违约责任          中小投资者      56,034,071    99.7566%   136,702   0.2434%         0   0.0000%

                           总体         106,998,246   99.8724%   136,702   0.1276%         0   0.0000%
议案 2.15:上市地点
                           中小投资者   56,034,071    99.7566%   136,702   0.2434%         0   0.0000%

议案 2.16:发行前滚存未 总体            106,994,446   99.8689%   136,702   0.1276%   3,800     0.0035%
分配利润安排            中小投资者      56,030,271    99.7499%   136,702   0.2434%   3,800     0.0068%

                           总体         106,998,246   99.8724%   136,702   0.1276%         0   0.0000%
议案 2.17:决议有效期
                           中小投资者   56,034,071    99.7566%   136,702   0.2434%         0   0.0000%

议案 3:关于公司发行股份
募集配套资金方案的议案


议案 3.01:发行股票的种 总体            55,944,071    99.5964%   226,702   0.4036%         0   0.0000%
类和面值                中小投资者      55,944,071    99.5964%   226,702   0.4036%         0   0.0000%




                                                                                       3
议案 3.02:发行方式和发 总体           56,034,071    99.7566%   136,702   0.2434%       0   0.0000%
行时间                  中小投资者     56,034,071    99.7566%   136,702   0.2434%       0   0.0000%

                                       56,034,071    99.7566%   136,702   0.2434%       0   0.0000%
议案 3.03:发行对象和认 总体
购方式                  中小投资者     56,034,071    99.7566%   136,702   0.2434%       0   0.0000%

                          总体         55,943,771    99.5959%   227,002   0.4041%       0   0.0000%
议案 3.04:发行价格
                          中小投资者   55,943,771    99.5959%   227,002   0.4041%       0   0.0000%

                          总体         55,943,771    99.5959%   227,002   0.4041%       0   0.0000%
议案 3.05:发行数量
                          中小投资者   55,943,771    99.5959%   227,002   0.4041%       0   0.0000%

                          总体         56,034,071    99.7566%   136,702   0.2434%       0   0.0000%
议案 3.06:限售期
                          中小投资者   56,034,071    99.7566%   136,702   0.2434%       0   0.0000%

                          总体         56,034,071    99.7566%   136,702   0.2434%       0   0.0000%
议案 3.07:募集资金用途
                          中小投资者   56,034,071    99.7566%   136,702   0.2434%       0   0.0000%

                          总体         56,034,071    99.7566%   136,702   0.2434%       0   0.0000%
议案 3.08:上市地点
                          中小投资者   56,034,071    99.7566%   136,702   0.2434%       0   0.0000%

                          总体         56,034,071    99.7566%   136,702   0.2434%       0   0.0000%
议案 3.09:滚存利润安排
                          中小投资者   56,034,071    99.7566%   136,702   0.2434%       0   0.0000%

                          总体         56,034,071    99.7566%   136,702   0.2434%       0   0.0000%
议案 3.10:决议有效期
                          中小投资者   56,034,071    99.7566%   136,702   0.2434%       0   0.0000%

议案 4:关于《南方双林生
物制药股份有限公司发行 总体            56,034,071    99.7566%   136,702   0.2434%       0   0.0000%
股份及支付现金购买资产
并募集配套资金暨关联交
易报告书(草案)》及其 中小投资者      56,034,071    99.7566%   136,702   0.2434%       0   0.0000%
摘要的议案
议案 5:关于签署附条件生
效的《发行股份购买资产 总体            106,998,246   99.8724%   136,702   0.1276%       0   0.0000%
协议》和《发行股份及支
付现金购买资产协议》的 中小投资者      56,034,071    99.7566%   136,702   0.2434%       0   0.0000%
议案




                                                                                    4
议案 6:关于签署附条件生
效的《发行股份购买资产 总体           106,998,246   99.8724%   136,702   0.1276%       0   0.0000%
协议之补充协议(一)》
和《发行股份及支付现金
购买资产协议之补充协议 中小投资者     56,034,071    99.7566%   136,702   0.2434%       0   0.0000%
(一)》的议案

议案 7:关于引进战略投资
者暨签署附条件生效的
《战略合作协议》的议案

议案 7.01:引进诚合有限
                         总体         141,701,391   99.9036%   136,702   0.0964%       0   0.0000%
公司与深圳市航运健康科
技有限公司作为战略投资
者并签署附条件生效的《战
                         中小投资者   56,034,071    99.7566%   136,702   0.2434%       0   0.0000%
略合作协议》

议案 7.02:引进付绍兰作 总体          192,665,566   99.9291%   136,702   0.0709%       0   0.0000%
为战略投资者并签署附条
件生效的《战略合作协议》 中小投资者   56,034,071    99.7566%   136,702   0.2434%       0   0.0000%

议案 8:关于签署附条件生 总体         56,034,071    99.7566%   136,702   0.2434%       0   0.0000%
效的《非公开发行股票认
购协议》的议案           中小投资者   56,034,071    99.7566%   136,702   0.2434%       0   0.0000%

议案 9:关于签署附条件生
                         总体         106,998,246   99.8724%   136,702   0.1276%       0   0.0000%
效的《非公开发行股票认
购协议之补充协议(一)》
                         中小投资者   56,034,071    99.7566%   136,702   0.2434%       0   0.0000%
的议案
议案 10:关于签署附条件 总体          106,998,246   99.8724%   136,702   0.1276%       0   0.0000%
生效的《业绩承诺补偿协
议》的议案              中小投资者    56,034,071    99.7566%   136,702   0.2434%       0   0.0000%

议案 11:关于本次发行股
                        总体          56,034,071    99.7566%   136,702   0.2434%       0   0.0000%
份及支付现金购买资产并
募集配套资金构成关联交
                        中小投资者    56,034,071    99.7566%   136,702   0.2434%       0   0.0000%
易的议案
                                      56,035,044    99.7584%   135,729   0.2416%       0   0.0000%
议案 12:关于本次重组构 总体
成重大资产重组的议案    中小投资者    56,035,044    99.7584%   135,729   0.2416%       0   0.0000%

议案 13:关于本次重组不
构成《上市公司重大资产 总体           56,035,044    99.7584%   135,729   0.2416%       0   0.0000%
重组管理办法》第十三条
规定的重组上市情形的议 中小投资者     56,035,044    99.7584%   135,729   0.2416%       0   0.0000%





                                                                                   5
议案 14:关于提请股东大
                        总体          56,035,044   99.7584%   135,729    0.2416%          0   0.0000%
会授权董事会以及董事会
授权的人士办理本次重组
                        中小投资者    56,035,044   99.7584%   135,729    0.2416%          0   0.0000%
相关事宜的议案
议案 15:关于批准本次重
                        总体          56,035,044   99.7584%   135,729    0.2416%          0   0.0000%
组相关的审计报告、备考
审阅报告和资产评估报告
                        中小投资者    56,035,044   99.7584%   135,729    0.2416%          0   0.0000%
的议案
议案 16:关于本次重组摊 总体          56,035,044   99.7584%   135,729    0.2416%          0   0.0000%
薄即期回报的填补措施的
议案                    中小投资者    56,035,044   99.7584%   135,729    0.2416%          0   0.0000%

议案 17:关于《未来三年 总体         192,666,539   99.9296%   135,729    0.0704%          0   0.0000%
(2020 年-2022 年)股东
回报规划》的议案        中小投资者    56,035,044   99.7584%   135,729    0.2416%          0   0.0000%

             三、律师出具的法律意见
             北京市嘉源律师事务所苏敦渊律师、栾恺律师列席了本次股东大会并出具了法
         律意见:本次股东大会的召集和召开程序合法、召集人和出席会议人员的资格、表
         决程序符合相关法律法规和《公司章程》的规定,合法有效,表决结果合法有效,
         本次股东大会通过的决议合法有效。(全文请见《北京市嘉源律师事务所关于南方双
         林生物制药股份有限公司 2020 年第四次临时股东大会法律意见书》)。

             四、备查文件
             1、经与会董事签字确认并加盖董事会印章的股东大会决议;
             2、《法律意见书》。

             特此公告。




                                                       南方双林生物制药股份有限公司

                                                                 董     事   会

                                                         二〇二〇年七月二十一日




                                                                                      6

关闭窗口